EANM guideline on quality risk management for radiopharmaceuticals

This document is intended as a supplement to the EANM “Guidelines on current Good Radiopharmacy Practice (cGRPP)” issued by the Radiopharmacy Committee of the EANM (Gillings et al. in EJNMMI Radiopharm Chem. 6:8, 2021). The aim of the EANM Radiopharmacy Committee is to provide a document that descri...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillings, Nic, Hjelstuen, Olaug, Behe, Martin, Decristoforo, Clemens, Elsinga, Philip H., Ferrari, Valentina, Kiss, Oliver C., Kolenc, Petra, Koziorowski, Jacek, Laverman, Peter, Mindt, Thomas L., Ocak, Meltem, Patt, Marianne, Todde, Sergio, Walte, Almut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308578/
https://www.ncbi.nlm.nih.gov/pubmed/35385986
http://dx.doi.org/10.1007/s00259-022-05738-4
Descripción
Sumario:This document is intended as a supplement to the EANM “Guidelines on current Good Radiopharmacy Practice (cGRPP)” issued by the Radiopharmacy Committee of the EANM (Gillings et al. in EJNMMI Radiopharm Chem. 6:8, 2021). The aim of the EANM Radiopharmacy Committee is to provide a document that describes how to manage risks associated with small-scale “in-house” preparation of radiopharmaceuticals, not intended for commercial purposes or distribution.

Ejemplares similares